Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy.
暂无分享,去创建一个
A. Jeremias | G. Stone | Z. Ali | G. Dangas | M. Leon | G. Weisz | R. Mehran | G. Mintz | G. Chertow | D. Cohen | M. Rinaldi | T. Stuckey | B. Witzenbichler | A. Kirtane | B. Redfors | A. Maehara | J. Radhakrishnan | R. Mohebi | Keyvan Karimi Galougahi | J. Horst | Shmuel Chen | D. Cohen | J. Garcia | O. Ben-Yehuda | D. Cohen
[1] S. Chadban,et al. Invasive Management of Coronary Artery Disease in Advanced Renal Disease , 2021, Kidney international reports.
[2] D. Leaf,et al. Soluble Urokinase Receptor and Acute Kidney Injury. , 2020, The New England journal of medicine.
[3] H. Krumholz,et al. Development and Validation of a Model for Predicting the Risk of Acute Kidney Injury Associated With Contrast Volume Levels During Percutaneous Coronary Intervention , 2019, JAMA network open.
[4] L. Newby,et al. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[5] Z. Ali,et al. Zero‐contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[6] C. Ronco,et al. Volume expansion and contrast-induced acute kidney injury , 2017, The Lancet.
[7] A. Patzak,et al. Understanding and preventing contrast-induced acute kidney injury , 2017, Nature Reviews Nephrology.
[8] G. Stone,et al. Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. , 2016, European heart journal.
[9] Z. Ali,et al. Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. , 2016, European heart journal.
[10] C. Guenancia,et al. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. , 2015, The American journal of cardiology.
[11] Junzhou Fu,et al. Neutrophil Gelatinase-associated Lipocalin in the Prediction of Contrast-induced Nephropathy: A Systemic Review and Meta-analysis , 2015, Journal of cardiovascular pharmacology.
[12] Lichuan Yang,et al. Novel risk score of contrast‐induced nephropathy after percutaneous coronary intervention , 2015, Nephrology.
[13] M. Velázquez,et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. , 2015, The American journal of cardiology.
[14] J. Coresh,et al. Explaining the racial difference in AKI incidence. , 2014, Journal of the American Society of Nephrology : JASN.
[15] M. Tonelli,et al. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. , 2014, Kidney international.
[16] Somjot S. Brar,et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial , 2014, The Lancet.
[17] R. Solomon. Contrast Media: Are There Differences in Nephrotoxicity among Contrast Media? , 2014, BioMed research international.
[18] Joel Stein,et al. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.
[19] Peter L Duffy,et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study , 2013, The Lancet.
[20] S. Weisbord,et al. Contrast-induced acute kidney injury: short- and long-term implications. , 2011, Seminars in nephrology.
[21] Deepak L. Bhatt,et al. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. , 2008, American heart journal.
[22] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[23] U. Varol,et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] Charles Davidson,et al. Risk prediction of contrast-induced nephropathy. , 2006, The American journal of cardiology.
[25] R. Mehran,et al. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.
[26] F. Veglia,et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[27] G. Stone,et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.
[28] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.
[29] S. Hou,et al. Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] W. O’Neill,et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.
[31] B. Barrett,et al. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.
[32] G. Dangas,et al. Contrast‐induced nephropathy , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[33] P. McCullough,et al. Epidemiology of contrast-induced nephropathy. , 2003, Reviews in cardiovascular medicine.
[34] Deeb N Salem,et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.
[35] H. S. Thomsen,et al. Contrast-media-induced nephrotoxicity: a consensus report , 1999, European Radiology.
[36] E. Halpern,et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. , 1995, Kidney international.
[37] G. Berlyne,et al. Acute renal failure following intravenous pyelography with hypaque. , 1962, Acta Medica Scandinavica.